Adis Journals
Browse
Summary Slide.png (122.04 kB)

Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease

Download (122.04 kB)
figure
posted on 2020-04-14, 15:42 authored by Cristian Guja, Juan P. Frías, Lisa Suchower, Elise Hardy, Galina Marr, C. David Sjöström, Serge A. Jabbour

The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Usage metrics

    Diabetes Therapy

    Categories

    Keywords

    ChronicCKD2CKD3ExenatideGlucagon-like peptide 1Pooled analysisRenal insufficiencySafetyType 2 diabetes mellitus

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC